Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $12.55 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $12.08, down -3.75%. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 1.06 million shares were traded. MNMD stock price reached its highest trading level at $12.76 during the session, while it also had its lowest trading level at $12.02.
Ratios:
Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on October 13, 2025, initiated with a Buy rating and assigned the stock a target price of $28. On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.Evercore ISI initiated its Outperform rating on January 28, 2025, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’25 when Sullivan Mark sold 11,278 shares for $9.77 per share. The transaction valued at 110,186 led to the insider holds 293,852 shares of the business.
Barrow Robert sold 25,797 shares of MNMD for $252,037 on Sep 25 ’25. The Chief Executive Officer now owns 804,268 shares after completing the transaction at $9.77 per share. On Sep 25 ’25, another insider, Karlin Daniel, who serves as the Chief Medical Officer of the company, sold 7,704 shares for $9.77 each. As a result, the insider received 75,268 and left with 430,625 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 1174407808 and an Enterprise Value of 1021907072.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.63, which has changed by 0.67780745 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $14.43, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is -1.25%, while the 200-Day Moving Average is calculated to be 35.05%.
Shares Statistics:
The stock has traded on average 1.89M shares per day over the past 3-months and 1606420 shares per day over the last 10 days, according to various share statistics. A total of 76.77M shares are outstanding, with a floating share count of 73.33M. Insiders hold about 2.94% of the company’s shares, while institutions hold 51.74% stake in the company. Shares short for MNMD as of 1764288000 were 12350292 with a Short Ratio of 6.52, compared to 1761868800 on 11841922. Therefore, it implies a Short% of Shares Outstanding of 12350292 and a Short% of Float of 12.61.
Earnings Estimates
The dynamic stock of Mind Medicine Inc (MNMD) is currently attracting attention from 7.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.43 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.99 and -$2.31 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.72, with 9.0 analysts recommending between -$1.0 and -$2.08.
